Detalles de la búsqueda
1.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331369
2.
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
Int J Clin Oncol
; 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555323
3.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871043
4.
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
Oncologist
; 28(11): e1108-e1113, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284901
5.
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
BMC Cancer
; 23(1): 726, 2023 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543568
6.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol
; 28(6): 756-763, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943545
7.
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
Int J Clin Oncol
; 28(5): 644-653, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899286
8.
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.
Esophagus
; 20(3): 524-532, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36595124
9.
Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient.
BMC Infect Dis
; 22(1): 529, 2022 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672730
10.
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
Support Care Cancer
; 30(5): 4497-4504, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113224
11.
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 22(6): 779-789, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33961795
12.
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.
Cancer Sci
; 112(1): 314-322, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33075166
13.
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.
Oncologist
; 26(10): 845-853, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232546
14.
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.
Invest New Drugs
; 39(6): 1649-1655, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019214
15.
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
BMC Cancer
; 21(1): 1159, 2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715820
16.
Open versus laparoscopic surgery for primary appendiceal tumors: a large multicenter retrospective propensity score-matched cohort study in Japan.
Surg Endosc
; 35(10): 5515-5523, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32995963
17.
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
Int J Clin Oncol
; 26(4): 701-707, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33386556
18.
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
Int J Clin Oncol
; 26(2): 355-363, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33063177
19.
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.
Int J Clin Oncol
; 26(11): 2017-2024, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34291369
20.
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer.
Int J Clin Oncol
; 26(11): 2025-2028, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476649